|1.||Zhao, Dong: 1 article (11/2012)|
|2.||Wang, Zhan-Yong: 1 article (11/2012)|
|3.||Zhou, Yan: 1 article (11/2012)|
|4.||Xiao, Bai: 1 article (11/2012)|
|5.||Wang, Jian-Qiu: 1 article (11/2012)|
|6.||Malkas, Linda H: 1 article (04/2009)|
|7.||Dai, Heqiao: 1 article (04/2009)|
|8.||Liu, Jianying: 1 article (04/2009)|
|9.||Hickey, Robert J: 1 article (04/2009)|
|10.||Kuchta, Robert D: 1 article (01/2009)|
|1.||Human Influenza (Influenza)
01/01/2009 - "An unusual feature of influenza viral -messenger RNA (mRNA) synthesis is its dependence upon host cell mRNAs as a source of capped RNA primers. "
04/17/2001 - "The cap-dependent endonuclease of the influenza viral RNA polymerase, which produces the capped RNA primers that initiate viral mRNA synthesis, is comprised of two active sites, one for cap binding and one for endonuclease cleavage. "
02/25/1980 - "RNA primers and the role of host nuclear RNA polymerase II in influenza viral RNA transcription."
09/01/1996 - "The RNA-binding domains of the NS1 proteins of these influenza A and B viruses share the following properties: (i) they specifically bind to the same three RNA targets, poly(A), U6 snRNA, and double-stranded (ds) RNA; (ii) a polypeptide containing an amino-terminal sequence of the protein possesses all the RNA-binding activity of the full-length protein and exists in the form of a dimer; (iii) the binding to U6 snRNA causes an inhibition of pre-mRNA splicing in vitro; and (iv) the binding to dsRNA blocks the activation of the PKR kinase in vitro. "
12/01/1997 - "This RNA, designated RNA II, is observed in a number of different cell lines, both early and late in infection. "
01/01/1978 - "The effect of a number of metabolic inhibitors was determined on: (i) the production of cellular immunity to infection with Mycobacterium tuberculosis in mice by vaccination with mycobacterial ribonucleic acid (RNA), (Ii) the production of cellular immunity to infection with M. "
09/20/1990 - "The following hypothesis is presented: most, possibly all, of the extra branching induced by removal of gene 6 exonuclease is caused by strand displacement DNA synthesis at the site of RNA primers of DNA synthesis; the RNA primers, produced by multiple initiations of DNA replication, are removed by the RNase H activity of gene 6 exonuclease during a wild-type T7 infection. "
07/01/1979 - "We found that, during the acute infection in vitro, (i) viral mRNA's amount to only 0.1% of the total cytoplasmic RNA, (ii) 20% of the total cytoplasmic viral RNA is found in polyribosomes, and (iii) three viral mRNA's can be identified by sucrose gradient sedimentation or polyacrylamide gel electrophoresis. "
09/01/1996 - "Bacteriophage P4's superinfection immunity mechanism is unique among those of other known bacteriophages in several respects: (i) the P4 immunity factor is not a protein but a short, stable RNA (CI RNA); (ii) in the prophage the expression of the replication operon is prevented by premature transcription termination rather than by repression of transcription initiation; (iii) transcription termination is controlled via RNA-RNA interactions between the CI RNA and two complementary target sequences on the nascent transcript; and (iv) the CI RNA is produced by processing of the same transcript it controls. "
03/01/1985 - "Superinfection of these cells with standard Semliki Forest virus showed that (i) the synthesis of SFV genomic RNA is marginally if at all affected by the svDI301 RNA, (ii) the svDI301 RNA is not replicated by SFV-RNA-dependent RNA polymerase, and (iii) packaging efficiency of the standard SFV genome RNA into virions is clearly decreased in the presence of svDI301 RNA. "
09/01/1995 - "In the presence of Mn2+, vaccinia PAP is able to tail RNA primers with tracts of 3'-oligo(U), oligo(C) and oligo(G). "
05/25/1985 - "About 80% of the RNA primers synthesized on an M13 DNA template were (p)ppA/G(pN)5-7, and 20% were (p)ppA/G(pN)0-4. RNA primer size was determined by gel electrophoresis after removing nascent DNA with phage T4 DNA polymerase 3'-5' exonuclease, leaving a single dNMP at the 3'-end of the RNA primer, and the terminal 5'-(p)ppN residue was determined by "capping" with [alpha-32P]GTP using vaccinia guanylyl-transferase. "
|1.||RNA (Ribonucleic Acid)
|3.||Messenger RNA (mRNA)
|4.||DNA (Deoxyribonucleic Acid)
|5.||Replication Protein A
|7.||DNA Primase (Primase)
|8.||Ribonuclease H (RNase H)